Live Breaking News & Updates on Presents First Ever Results

Stay updated with breaking news from Presents first ever results. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Johnson & Johnson : Janssen Presents First-Ever Results from Dual Bispecific Combination Study Showing 96 Percent Overall Response Rate in Patients with Relapsed or Refractory Multiple Myeloma

News Release

Media Contact: Christie Corbett +1 857-636-0211

Satu Glawe +49 172-294-6264

Investor Relations: Raychel. | June 5, 2023 ....

United States , Arnob Banerjee , Satu Glawe , Christie Corbett , Yael Cohen , European Commission , National Comprehensive Cancer Network , Early Development Oncology , American Society Of Clinical Oncology , Janssen Pharmaceutical Companies Of Johnson , Janssen Research Development , Aviv Sourasky Medical Center , Hematology Institute , News Release , Presents First Ever Results , Dual Bispecific Combination , Overall Response Rate , Refractory Multiple Myeloma , Janssen Pharmaceutical Companies , Clinical Oncology , Annual Meeting , Myeloma Unit , Tel Aviv Sourasky Medical Center , Confidence Interval , Not Estimable , Global Medical Head ,